Welcome to our dedicated page for Worthington Steel news (Ticker: ws), a resource for investors and traders seeking the latest updates and insights on Worthington Steel stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Worthington Steel's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Worthington Steel's position in the market.
Vicarious Surgical reported a cash burn of $67 million for 2022, meeting its objective, and announced initiatives to extend its cash runway. The company expects 2023 cash burn between $55-$65 million. Vicarious Surgical's operating expenses surged to $80.1 million in 2022 versus $38.2 million in 2021, with an adjusted net loss of $78.8 million, or $0.65 per share. Despite a GAAP net income of $5.2 million for the year, the company reported significant losses. Notable achievements include the completion of the Beta 2 robotic system and partnerships with major healthcare providers, enhancing its market position.
Kaleyra, Inc. (NYSE: KLR, KLR WS) will announce its Q4 and full-year 2022 financial results on February 15, 2023, at 4:30 PM ET. The call will be hosted by CEO Dario Calogero, CFO Giacomo Dall'Aglio, and Investor Relations VP Colin Gillis, featuring a presentation followed by a Q&A session. Interested parties can join the call by dialing 1-855-327-6837 (US) or 1-631-891-4304 (international) ten minutes before the start. A replay will be available post-call until February 22, 2023, via toll-free number 1-844-512-2921. Kaleyra provides CPaaS services to diverse sectors globally, managing vast messaging traffic securely.
Tailwind Acquisition Corp. (NYSE American: TWND, TWND.U, TWND WS) has completed its business combination with NUBURU, Inc., an innovator in industrial blue laser technology. NUBURU is now publicly listed, with its stock trading under the ticker 'BURU' starting February 1, 2023. The CEO of NUBURU, Dr. Mark Zediker, expressed optimism about gaining capital access and accelerating product development. The combined entity aims to strengthen its market position in sectors such as 3D printing and aerospace, highlighting innovations like the new BL-series blue lasers showcased at Photonics West.
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will report its financial results for the fourth quarter and full year ended December 31, 2022, after market close on February 13, 2023. A conference call will follow at 4:30 p.m. ET for management to discuss the results. Investors can join by calling +1 (646) 904 5544 domestically or +1 (929) 526 1599 internationally. The company develops advanced surgical robotics aimed at improving the efficiency of procedures and reducing costs, using proprietary technology to perform minimally invasive surgeries.
Summary not available.
Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) announced a significant expansion at Dallas's Addison Airport (ADS), doubling its footprint to approximately 195,000 rentable square feet. The CEO, Tal Keinan, highlighted Dallas as a key market for business jets, enhancing the airport's attractiveness for private and corporate flight departments. Sky Harbour operates campuses at Houston's Sugar Land Regional Airport and Nashville International Airport, with a Miami campus set to open soon. New facilities are also in development at Denver Centennial and Phoenix Deer Valley Airports.
ROSS Acquisition Corp II (NYSE: ROSS,WS) has entered into a definitive agreement to merge with APRINOIA Therapeutics, a clinical-stage biotech focused on neurodegenerative diseases. The transaction is valued at $280 million, with funding aimed at advancing APRINOIA's therapeutic programs, including its lead product, APN-1607. The merger, expected to close in the first half of 2023, will create a publicly traded entity on Nasdaq or NYSE. APRINOIA holds agreements with major biotech firms such as Biogen, and anticipates significant market opportunities in treating Alzheimer’s Disease, which affects an estimated 10 million individuals in China alone.
Ares Acquisition Corporation (NYSE: AAC) announced the postponement of its extraordinary general meeting of shareholders from January 24, 2023, to February 2, 2023, at 9:30 a.m. ET. The meeting will address the Extension Amendment Proposal, which seeks to extend the deadline for completing a business combination from February 4, 2023, to August 4, 2023. The proposal also aims to remove restrictions on share repurchases and the minimum net tangible assets requirement. Additionally, the deadline for shareholders to submit redemption requests has been extended to January 31, 2023. Shareholders of record as of December 15, 2022, are eligible to vote.
Golden Falcon Acquisition Corp. (GFX) announced the adjournment of its Special Meeting originally scheduled for December 16, 2022, to December 20, 2022. The meeting aims to vote on four proposals, including an amendment to extend the deadline for completing a business combination to June 22, 2023. Other proposals include re-electing two board directors and ratifying their independent auditor for fiscal 2022. Stockholders are encouraged to submit or change their proxies ahead of the meeting, which remains open for questions via their proxy solicitor.
Graf Acquisition Corp. IV (NYSE: GFOR) has withdrawn its Extension Proposal to delay the deadline for a business combination from May 25, 2023 to September 29, 2023. This decision comes ahead of the special stockholder meeting scheduled for December 21, 2022. Consequently, shareholders will not have the option to redeem shares for a pro rata portion of the trust account funds. Shares already submitted for redemption will be returned promptly. The withdrawal does not affect three other proposals on the ballot.